Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2020 - 2024)

Corbus Pharmaceuticals Holdings has reported Debt Ratio over the past 4 years, most recently at 0.56 for Q4 2023.

  • For Q4 2023, Debt Ratio rose 99.17% year-over-year to 0.56; the TTM value through Dec 2023 reached 0.56, up 99.17%, while the annual FY2023 figure was 0.56, 99.17% up from the prior year.
  • Debt Ratio for Q4 2023 was 0.56 at Corbus Pharmaceuticals Holdings, up from 0.0 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.56 in Q4 2023 and troughed at 0.0 in Q3 2023.
  • A 4-year average of 0.22 and a median of 0.19 in 2020 define the central range for Debt Ratio.
  • On a YoY basis, Debt Ratio climbed as much as 99.17% in 2023 and fell as far as 99.61% in 2023.
  • Year by year, Debt Ratio stood at 0.18 in 2020, then decreased by 5.53% to 0.17 in 2021, then surged by 62.9% to 0.28 in 2022, then soared by 99.17% to 0.56 in 2023.
  • Business Quant data shows Debt Ratio for CRBP at 0.56 in Q4 2023, 0.0 in Q3 2023, and 0.26 in Q2 2023.